| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 01/19/2005 | CN1568312A Biphenylcarboxamides useful as lipid lowering agents |
| 01/19/2005 | CN1568310A Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1566090A Chemical synthesis of 1-chloroformyl succinimide |
| 01/19/2005 | CN1566065A Alpha position heteroatom substituted gamma aryl ketobutyric acid derivative, process, pharmaceutical combination and uses thereof |
| 01/19/2005 | CN1185250C Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/19/2005 | CN1185223C Novel Compounds and methods for synthesis and therapy |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/18/2005 | US6844447 Chemical intermediates can be used as solvents (e.g., coalescing solvents, cleaning solvents), process additives, plasticizers, surface active agents, in the formulation of products (e.g., industrial products, consumer products), |
| 01/18/2005 | US6844446 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 01/13/2005 | WO2005003108A1 Quaternary ammonium salt, electrolyte, and electrochemical device |
| 01/13/2005 | WO2005003090A1 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists |
| 01/13/2005 | WO2004099134A3 Glutaminyl based dp iv-inhibitors |
| 01/13/2005 | US20050010060 Novel quinones as disease therapies |
| 01/13/2005 | US20050010057 Method for the continuous production of n-methyl-2-pyrrolidone (nmp) |
| 01/13/2005 | US20050010049 Metal catalysts and methods for making and using same |
| 01/13/2005 | US20050009930 Carotenoid analogs or derivatives for controlling connexin 43 expression |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/13/2005 | US20050009788 The analog includes a conjugated polyene with 7 to 14 double bonds and a 3,3-dimethylcyclohexenylene or 3,3-dimethylcyclohexen-6-onylene ring; especially for treating cardiac arrhythmia and cancerous and pre-cancerous cells |
| 01/13/2005 | US20050009786 Immunosuppressant compounds and compositions |
| 01/13/2005 | US20050009758 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 01/13/2005 | US20050009704 Substituted aryl ketones |
| 01/13/2005 | DE10297418T5 Maleinsäure-Derivat und härtbare Zusammensetzung, die dieses enthält Maleic acid derivative and curable composition containing this |
| 01/13/2005 | CA2525801A1 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists |
| 01/12/2005 | EP1495015A1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494663A1 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss |
| 01/12/2005 | EP1299383B1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/12/2005 | EP1204639B1 Synthesis of a novel paramagnetic amino acid derivative (epm-5) for labelling chemical and biological macromolecules |
| 01/12/2005 | EP1098877A4 Derivatized polymers of alpha-olefin-maleic anhydride alkyl half-ester or full acid |
| 01/12/2005 | CN1564685A Pyrrolidinone derivatives |
| 01/12/2005 | CN1562969A Method for preparing instable substituent N-containing pair of alkali-ethylene substitution pyrrole |
| 01/12/2005 | CN1562968A Method for synthesizing N-substitution pyrrole in ion liquid |
| 01/12/2005 | CN1184195C Succinimide-acid compound and its derivative |
| 01/11/2005 | US6841553 Contorlling fertility |
| 01/11/2005 | US6841520 Production of 5-methyl-N-(methyl aryl)-2-pyrrolidone, 5-methyl-N-(methyl cycloalkyl)-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid with cyano compounds |
| 01/11/2005 | US6840965 P-aminophenols and colorants containing said compounds |
| 01/11/2005 | CA2192555C 2-acylaminopropanol compound and medicinal composition |
| 01/06/2005 | WO2005000839A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | WO2005000824A1 Lazolidine derivatives as herbicidal agents |
| 01/06/2005 | WO2005000815A2 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor |
| 01/06/2005 | WO2005000811A1 3-aminopyrrolidines as inhibitors of monoamine uptake |
| 01/06/2005 | WO2005000810A1 Process for producing nitrogenous heterocyclic compound |
| 01/06/2005 | WO2005000309A2 Chemical compounds |
| 01/06/2005 | WO2004071449A3 Lactams as modulators of chemokine receptor activity |
| 01/06/2005 | WO2004071382A3 Substituted heterocycles |
| 01/06/2005 | WO2004069796A3 Process for producing levetiracetam |
| 01/06/2005 | US20050004371 Screening libraries; peptide mimetics; reacting valerolactone compound with aldehyde and tertiary amine in presence of crown ether |
| 01/06/2005 | US20050004235 Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease |
| 01/06/2005 | US20050004230 Retroviral protease inhibitors |
| 01/06/2005 | US20050004206 suspending crystal strutured or amorphous lipitor in diluents comprising alcohols and/or water mixtures to cause conversion, then separating the diluents; monodispersity |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004180 Conditions mediated by beta chemokine receptor 2, monocyte chemotactic protein 1 and/or their interaction; such as 4-acetyl-5-cyclohexyl-3-amino-1-(4-methylphenyl)-1,5-dihydro-2H-pyrrol-2-one |
| 01/06/2005 | US20050004119 Trypsin like serine protease enzyme inhibitors |
| 01/06/2005 | US20050004112 C-fms kinase inhibitors |
| 01/06/2005 | US20050004109 Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia |
| 01/06/2005 | US20050004100 Cardiovascular disorders; kidney disorders; antiinflammatory agents |
| 01/06/2005 | US20050003448 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 01/06/2005 | US20050000791 Process for fractionating water-containing crude amine mixtures from amine synthesis |
| 01/06/2005 | CA2672071A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | CA2530377A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/05/2005 | EP1493731A1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and these derivatives |
| 01/05/2005 | EP1492876A1 Cationic amphiphiles for intracellular delivery of therapeutic molecules, composition, process and use thereof |
| 01/05/2005 | EP1492777A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidase inhibitors |
| 01/05/2005 | EP1492757A1 (2-((2-alkoxy)-phenyl)-cyclopent-1-enyl) aromatic carbo- and heterocyclic carboxylic acid and derivatives |
| 01/05/2005 | EP1492539A1 Statin therapy for enhancing cognitive maintenance |
| 01/05/2005 | EP1492518A2 Tuberculosis treatment using pleuromutilin derivatives |
| 01/05/2005 | EP1150648A4 Use of water-soluble/dispersible reactive derivatives of polyimido compounds for modifying proteinaceous substrates |
| 01/05/2005 | CN1561341A Hydrolysis of [R(R*, R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 01/05/2005 | CN1561333A Aromatic and heteroaromatic acid halides for synthesizing polyamides |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1561326A Alpha-haloenamine reagents |
| 01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 01/04/2005 | US6838567 Process for producing optically active azetidine-2-carboxylic acids |
| 01/04/2005 | US6838479 Amidine inhibitors of serine proteases |
| 01/04/2005 | US6838478 Use as anticoagulants; competitive inhibitors of thrombin; for example, 1-(phenyl-2-hydroxyethane-1,1-diylcarbonyl), 2-((4-amidinophenyl)-alkylaminocarbonyl)azetidine |
| 01/04/2005 | CA2148827C Novel 3,3-diphenylpropylamines, their use and preparation |
| 01/04/2005 | CA2133091C Process for the manufacture of (s)-3-amino-1-substituted-pyrrolidines |
| 12/30/2004 | US20040267028 Such as 2-amino-1-(2-chlorophenyl)-5-(4-chlorophenyl)-N-cyclohexyl-1H-pyrrole-3-carboxamide hydrochloride |
| 12/30/2004 | US20040267015 Bactericides |
| 12/30/2004 | US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 12/30/2004 | US20040266781 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams |
| 12/30/2004 | US20040266740 7-pyrollyl 9-aminoacyl tetracycline compounds and methods of use thereof |
| 12/30/2004 | DE10326303A1 Reagenzien zur Modifikation von Biopharmazeutika, deren Herstellung und Anwendung Reagents for the modification of biopharmaceuticals, their preparation and application |
| 12/29/2004 | WO2004113394A2 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom |
| 12/29/2004 | WO2004113391A2 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 12/29/2004 | WO2004113297A2 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2004 | WO2004113290A1 Substituted alkylamides |
| 12/29/2004 | WO2004113289A2 Glycosidase inhibitors and methods of synthesizing same |
| 12/29/2004 | WO2004113280A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 12/29/2004 | WO2004113277A2 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | WO2004113275A2 Methods and compositions for treating amyloid-related diseases |
| 12/29/2004 | WO2004086050A3 Labelling agents for mass spectrometry comprising tertiary amines |
| 12/29/2004 | WO2004085047A3 Production of n-(methyl-aryl)-2-lactam, n-(methylcycloaklyl)-2-lactam and n-alkyl-2-lactam |
| 12/29/2004 | WO2004084840A3 Production of n-aryl-2-lactam and n-cycloalkyl-2-lactam by reductive amination of lactones with aryl amines |
| 12/29/2004 | WO2004002940A8 Inhibitors of hcv ns5b polymerase |
| 12/29/2004 | EP1491530A1 Method of heightening optical purity of 1-benzyl-3-aminopyrrolidine and salt for use therein |
| 12/29/2004 | EP1490333A1 New atorvastatin salts and pharmaceutical compositions containing them |
| 12/29/2004 | EP1490328A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation |